Category: Press Releases

Rueil-Malmaison (France), February 28, 2022 – Schneider Electric, the global leader in the digital transformation of energy management and automation, today announced its work with the World Woman Foundation to promote the role of women in the energy sector.

To mark International Women’s Day on March 8, women leaders from the world of energy will share their stories to inspire young women and girls to persevere with their personal and professional aspirations. The World Woman Hour online event premiers on Facebook Watch and LinkedIn Live on March 8 at 1 PM EST and will then be available on demand.

The five female energy leaders featured include:

• Damilola Ogunbiyi, CEO and Special Representative of the UN Secretary-General for Sustainable Energy for All and Co-Chair of UN-Energy;
• Sophie Borgne, Senior Vice President Digital Power at Schneider Electric;
• Bhavani Amirthalingam, Senior Vice President and Chief Digital Information Officer at U.S. energy company Ameren;
• Zanélle Dalglish, Sustainable Development and Training Academy Director for Schneider Electric in Southern Africa;
• Angie Redondo Herrera, Digital Marketing Specialist at Schneider Electric and recent winner of Schneider’s annual GoGreen student competition.

“Women are underrepresented in STEM fields, so with the World Woman Foundation, we aim to shine a light on the positive contribution women are making in the world of energy today,” said Charise Le, Chief Human Resources Officer at Schneider Electric. “We continue to challenge gender stereotypes and inequality to foster a gender-balanced workplace and #BreakTheBias.”

The World Woman Foundation is a global community of 15,000 members committed to scaling and accelerating the impact of women and girls through long-term investments to expand skills, connections, capacity, and visibility. Over the last five years, it has built a network of 300 change-makers and 55,000 Global Mentorship Program graduates in 20 countries.

Working with the World Woman Foundation is just one of the actions taken by Schneider Electric as part of its commitment to gender equality. Schneider’s wider 2025 sustainability goals include working towards targets to boost female representation across different levels of the workforce. In 2021, Schneider passed a gender-diversity milestone as women now make up 44% of its Executive Committee.

Schneider’s inclusive work policies support gender equity by helping employees to better manage their work and personal lives – for example, through flexible work or providing family, care and bereavement paid leave. Schneider also seeks to ensure equal pay across comparable groups of employees and reduce the pay gap between women and men to less than 1% by 2025.

For more information about Schneider’s commitment to women’s empowerment and diversity, equity and inclusion, click here.

About Schneider Electric

Schneider’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On.

Our mission is to be your digital partner for Sustainability and Efficiency.

We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries.

We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values.

www.se.com

Follow us on:      

Discover the newest perspectives shaping sustainability, electricity 4.0, and next generation automation on Schneider Electric Insights.

Hashtags: #LifeIsOn #SEGreatPeople #Meaningful #Inclusive #Empowered #OurImpact #BreakTheBias

Attachment

• Schneider Electric joins World Woman Hour to inspire future generations of women to work in energy

• In a letter last week to the U.S. Department of Defense, seventeen retired generals, admirals and officers across four U.S. military branches warned that decades of failure to address domestic critical mineral reserves and processing capacity leave the U.S. extremely vulnerable to supply chain shocks, and called upon the DoD to consider the responsible development of the vast polymetallic nodule resource in the CCZ
• As part of his government’s Vision 2030 investment plan, French President Emmanuel Macron has committed over €300 million for deep-sea mineral exploration to understand environmental impacts and potential to secure mineral independence, while the Indian Government under President Modi has allocated $600 million for its ‘Deep Ocean Mission’, including investments to undertake the necessary resource definition work on its polymetallic nodule contract area in the Indian Ocean
• Senator Lisa Murkowski (R-AK), a thought leader on energy and critical minerals issues in the U.S. Senate, urged Energy Secretary Jennifer Granholm in a letter to focus on securing access to battery raw materials and explore the potential of polymetallic nodules in the Clarion-Clipperton Zone (CCZ)

NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) — The Metals Company (NASDAQ: TMC) (the “Company” or “TMC”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today commended Western political and military leaders for their growing acknowledgement of the potential for seafloor polymetallic nodules to bolster domestic critical mineral supply chains for the clean energy transition.

Seventeen high-ranking U.S. military officers including former Director of National Intelligence Admiral Dennis Blair said in a letter to the U.S. Secretary of Defense, “The national security imperative of creating sufficient mineral supplies to build future EVs, energy infrastructure from turbines to transmission, and modern aerospace and defense systems must include a robust and secure supply chain within U.S. control.”

In the letter, attached to a LinkedIn post by Former Commander Kirk Lippold, the Officers wrote: “Given the known lack of domestic supply and processing of critical lithium-ion battery cathode materials including cobalt, nickel, and manganese, the U.S. should consider responsible development of polymetallic nodules found on the seafloor in U.S. territorial and international waters off the U.S. coast as a potential game-changer for U.S. critical mineral supply lines and domestic processing opportunities.”

In a letter to the U.S. Energy Secretary Jennifer Granholm earlier this month, Senator Lisa Murkowski (R-AK) wrote, “New and abundant sources of supply, such as polymetallic nodules, offer a pathway to mineral security for the United States.”

Senator Murkowski added in the letter: “In addition to focusing on conventional mining strategies, in the past I have also sought to direct funding for the federal government to assess seafloor mineral resources as a potential mechanism to enhance the security and sustainability of supplies available to the United States. It is my understanding that polymetallic nodules in the Pacific Ocean’s Clarion Clipperton Zone, which sit unattached atop the seafloor, can be collected to provide enough nickel, copper, cobalt, and manganese to electrify the world’s vehicle fleet several times over.”

Gerard Barron, Chairman and CEO of The Metals Company, said, “Today, China dominates nickel processing and Russia is the largest miner of Class 1 nickel, which has risen in price nearly 30% in the last two months. This doesn’t have to be a sign of what is to come for the clean energy transition. It is heartening to hear a growing international chorus of support for polymetallic nodules from political thought leaders and the military community who recognize the potential for seafloor minerals to re-shore supply chains and re-industrialize economies while reducing the social and environmental impacts of land-based mining.”

Meanwhile as part of its Vision 2030 investment plan, the French Government is investing over 300 million euros to support deep-sea exploration for polymetallic nodules. During the One Ocean Summit last week, France’s Secretary General for the Sea, Denis Robin, reaffirmed the country’s commitment and said that recent calls for a moratorium on such activities would mean maintaining a “veil of ignorance” on what happens deep below the ocean’s surface, adding: “There is nothing that justifies stopping us gathering this information.” Last October, French President Emmanuel Macron said deep-sea exploration was an essential part of understanding life in these remote regions, which could also provide “access to certain rare metals”.

France holds two seafloor minerals exploration contracts with the International Seabed Authority: a polymetallic nodule contract in the Clarion Clipperton Zone (CCZ) of the Pacific Ocean and a polymetallic sulphides contract in the Mid-Atlantic Ridge. France’s commitment to invest in deep-sea exploration echoes similar investments by a number of other sovereign states. Last July, the Indian Government under President Modi allocated $600 million over the next five years for its ‘Deep Ocean Mission’, including investments to undertake the necessary resource definition work on its polymetallic nodule contract area in the Central Indian Ocean Basin (CIOB) and to develop an integrated nodule collection system. Investment in deep-sea exploration is also a national priority in China, which holds three polymetallic nodule contracts in the CCZ, more than any other country. Other countries that directly hold exploration contracts or sponsor private company contracts in the CCZ include the United Kingdom, Belgium, Jamaica, the Republic of Korea, and Russia, as well as TMC’s sponsoring states, the Republics of Nauru and Kiribati, and the Kingdom of Tonga.

These latest interventions follow the White House’s earlier 100-day supply chain review, published last year, which elevated battery-grade nickel to ‘critical’ status and singled out the establishment of domestic nickel refining capacity as its highest priority, given the absence of domestic production and refining. The review also noted the potential for seafloor nodules to “provide a significant future source of strategic and critical materials” like nickel and cobalt. Once uplifted from the seafloor, polymetallic nodules can be shipped anywhere in the world for processing and, as the world’s largest nickel development project — according to Mining.com — The Metals Company’s NORI-D polymetallic nodule project could help re-shore critical mineral supply chains for the clean energy transition.

About The Metals Company

TMC the metals company Inc. (The Metals Company) is an explorer of lower-impact battery metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for the clean energy transition with the least possible negative environmental and social impact and (2) accelerate the transition to a circular metal economy. The company through its subsidiaries holds exploration rights to three polymetallic nodule contract areas in the Clarion Clipperton Zone of the Pacific Ocean regulated by the International Seabed Authority and sponsored by the governments of Nauru, Kiribati and the Kingdom of Tonga. More information is available at www.metals.co.

Forward Looking Statements
Certain statements made in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside TMC’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: regulatory uncertainties and the impact of government regulation and political instability on TMC’s resource activities; changes to any of the laws, rules, regulations or policies to which TMC is subject; the impact of extensive and costly environmental requirements on TMC’s operations; environmental liabilities; the impact of polymetallic nodule collection on biodiversity in the CCZ and recovery rates of impacted ecosystems; TMC’s ability to develop minerals in sufficient grade or quantities to justify commercial operations; the lack of development of seafloor polymetallic nodule deposit; uncertainty in the estimates for mineral resource calculations from certain contract areas and for the grade and quality of polymetallic nodule deposits; risks associated with natural hazards; uncertainty with respect to the specialized treatment and processing of polymetallic nodules that TMC may recover; risks associated with collective, development and processing operations; fluctuations in transportation costs; testing and manufacturing of equipment; risks associated with TMC’s limited operating history; the impact of the COVID-19 pandemic; risks associated with TMC’s intellectual property; and other risks and uncertainties, including those in the “Risk Factors” sections, included in the final prospectus and definitive proxy statement, dated and filed with the Securities and Exchange Commission (the “SEC”) on August 12, 2021 relating to the business combination, in TMC’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, filed by TMC with the SEC on November 15, 2021, and in TMC’s other future filings with the SEC. TMC cautions that the foregoing list of factors is not exclusive. TMC cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. TMC does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based except as required by law.

More Info

Media | media@metals.co
Investors | investors@metals.co

HOUSTON, Feb. 28, 2022 (GLOBE NEWSWIRE) — Petróleos Internacionales del Caribe (“PIC”) and its operating division in Mexico, Petróleos Internacionales del Caribe Inc., Sucursal México (“PICMEX”) and SeaOne Holdings, LLC (“SeaOne”™) jointly announced today the signing of a Memorandum of Understanding (“MOU”) for an exclusive license agreement for PIC to commercialize SeaOne’s patented Compressed Gas Liquids (CGL™) technology, systems and designs in the Americas’ 300 nautical mile Exclusive Economic Zone (“EEZ”).

The SeaOne intellectual property covered by the license is supported by 9 core U.S. patents with supporting engineering and designs. The core CGL patents are the basis of 84 international patents, and 72 global trademarks that cover the composition delivery of CGL (natural gas and natural gas liquids in a solvated solution) and methods for producing, storage, loading, handling and unloading cargo containment systems in CGL Carriers (CGLCs), and associated onshore and offshore production and receiving terminals. The patents, designs and systems also include various transportation solutions that have been developed by SeaOne.

The MOU and partnership between PIC and SeaOne represents a significant milestone in the commercialization of CGL as it signals the commencement of a project specific pre-FEED (Front End Engineering Design) studies by SeaOne. These studies will cover the design of the production and export terminals and plants, receiving terminals and plants, and the CGLC Fleet that will be built to transport CGL and deliver fuel to PIC’s markets in Mexico. Following completion of the pre-FEED studies and Final Investment Decision (FID) by PIC, SeaOne will undertake the FEED for final design and construction for the projects in Mexico that PIC has positioned.

“We are very enthusiastic about partnering with PIC,” SeaOne’s Chairman and CEO, Forrest Hoglund, said. “CGL increases access to affordable, lower emission fuels. These projects will provide Mexico, and other countries in Central and South America, and the Americas with affordable fuels and power, as well as significant carbon emissions reductions, a key component in achieving sustainability and balanced ESG goals.”

“We are excited to take this important step with SeaOne,“ said Michael Hood, CEO of PIC. “Through this partnership, PIC and SeaOne will accelerate commercialization of CGL to help meet the fuel supply and electricity needs of PIC’s customers in Mexico and throughout the Americas while substituting higher-emission fuels to continue driving down emissions towards a greener brighter future.”

About Petroleós Internacionales del Caribe and Petroleós Internacionales del Caribe Inc., Sucursal México
Petroleós Internacionales del Caribe (“PIC”) is a global company based in the USA. The company develops and operates a variety strategic related operations with its key partnerships. Petróleos Internacionales del Caribe Inc., Sucursal México (“PICMEX”) is an affiliate of PIC and is headquartered in Mexico. For more information, please visit www.pic-sas.com.

About SeaOne Holdings, LLC

Houston-based SeaOne Holdings, LLC (“SeaOne™”) is a midstream infrastructure and logistics company that delivers and stores natural gas and natural gas liquids, from wellhead to market, as a liquid gas cargo using through its patented Compressed Gas Liquid (“CGL”) system. SeaOne has developed and secured worldwide patents on a system which transforms the way natural gas and natural gas liquids (“NGLs”) are processed, stored, and delivered globally to markets. The technology enables the delivery of clean fuels to regional markets at a significant discount to the current cost of fuel in the Caribbean, Central and South America. SeaOne aims to remake the energy cost and supply picture for the entire region, catalyzing new opportunities for economic growth and vitality and improving the lives of millions. For more information, please visit www.seaone.com.

For media queries, please contact:

Jay Shahidi
PIC USA-PIC Mexico
info@pic-sas.com
+1 714 553 7482

For media queries, please contact:

Langley Wall
SeaOne Holdings, LLC
info@seaone.com
+1 713 739 3043

PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world

BARCELONA, Spain, Feb. 28, 2022 (GLOBE NEWSWIRE) — In the run up to Rare Disease Day, which is held on 28 February, International pharmaceutical company Ferrer has strengthened its focus on pulmonary vascular and interstitial lung diseases, as well as neurological disorders, by announcing today the signing of a distribution agreement with United Therapeutics Corporation (Nasdaq: UTHR) for Tyvaso® (treprostinil) inhalation solution – a pharmaceutical drug-device combination product for the treatment of WHO Group 3 pulmonary hypertension associated with interstitial lung disease (PH-ILD) ⁴.

According to Mario Rovirosa, Ferrer’s Chief Executive Officer, “This is an important milestone for Ferrer, a B Corp company. As a company, we aim to deliver the best possible solutions to underserved patients around the globe by promoting a new way of doing business and approaching the world.”

Under the agreement, Ferrer has been appointed as the exclusive, worldwide distributor (except for the U.S., Canada, Japan, China and Israel), to commercialise this therapeutic option for the treatment of PH-ILD – a rare, serious and progressive disease without an approved treatment in Europe and many other parts of the world^1-3.

“We’re proud of our strong and lasting relationship with Ferrer, and this distribution agreement has the potential to bring Tyvaso to PH-ILD patients in need worldwide, who currently have no other treatment options,” stated Michael Benkowitz, President and Chief Operating Officer, United Therapeutics. “Having recently converted into a public benefit corporation ourselves, we applaud and share Ferrer’s patient-driven mission – underscored by its recent B Corp certification.”

The agreement leverages Ferrer’s strong capabilities and expertise in pulmonary vascular and interstitial lung diseases and underscores both companies’ commitment to expanding global access to treprostinil inhalation solution for the treatment of PH-ILD.

“Tyvaso is the perfect fit for Ferrer’s mission to create lasting change by bringing transformative products in this challenging field to market and strengthens our pipeline for the coming years,” added Oscar Pérez, Chief Business Development and Global Alliances Officer, Ferrer.

Ferrer is a long-term partner of United Therapeutics, responsible for providing global access to Remodulin^® (treprostinil) Injection, a prostacyclin vasodilator for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to reduce symptoms associated with exercise.

“We’ve found Ferrer to be an excellent partner for the distribution of our treprostinil-based products around the world and are thrilled to expand our collaboration. Without Ferrer, patients outside of our core markets would not have access to these life-sustaining therapies,” commented Beth Rhodes, Vice President, Global Supply Chain and Alliance Management, United Therapeutics.

Upon signing, Ferrer made a down payment to United Therapeutics, who will also receive a transfer price and revenue sharing on future sales of this product by Ferrer.

Ferrer is now working with health authorities to determine the appropriate regulatory pathway to obtain approval for this product (currently only authorised in the US) for the treatment of PH-ILD in other territories.
For more information, please contact:
Emma Simms
BDB Account Director
emma@bdb.co.uk
+44 (0) 161 925 4700

Related Images

Image 1: Ferrer

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Ferrer

• Holds a virtual ceremonial event for the first time to mark the anniversary with its global employees

• Pledges to keep innovating access to biologic medicines worldwide

INCHEON, Korea, Feb. 28, 2022 (GLOBE NEWSWIRE) —  Samsung Bioepis Co. Ltd. today celebrated its 10^th anniversary of its establishment by reflecting the past, present and the future of its passion for health in increasing patient access to quality biologic medicines. The company held a virtual ceremonial event to mark the company’s anniversary with its global employees.

“I am very proud of our colleagues here at Samsung Bioepis as their hard work have made it possible for us to have six products approved and five marketed around the world, increasing patient access to medicines. We have made remarkable achievements with a proven track record in just a decade which is unprecedented in biopharmaceutical industry,” said Christopher Hansung Ko, President and Chief Executive Officer at Samsung Bioepis. “We are continuing to make history by pioneering in ophthalmology biosimilars, innovating the global healthcare landscape for caregivers, physicians and patients alike. Seeing what we have built together over the last decade makes me optimistic about the future of our company and of the biosimilar industry.”

Samsung Bioepis was established in 2012 with a mission to increase patient access to quality medicines through the development of biosimilars. In 2016, the company had its first product, SB4, a biosimilar to Enbrel^® (etanercept), gained the European Commission (EC)’s approval and in the span of five years, added five additional products to its portfolio, ranging from immunology, oncology to ophthalmology. Its latest product, SB11, a biosimilar to Lucentis^® (ranibizumab), was the first ophthalmology biosimilar approved by both the EC and the U.S. Food and Drug Administration (FDA) in August and September 2021, respectively.

Besides the six approved products, Samsung Bioepis has four other biosimilar candidates in the stage of Phase 3 clinical development – SB12, SB15, SB16 and SB17 covering a spectrum of therapeutic areas including ophthalmology, hematology and endocrinology.

With the goal of becoming a socially responsible and sustainable company, Samsung Bioepis published its very first sustainability report in 2021, highlighting the company’s Environment, Social and Governance (ESG) performance. The report details Samsung Bioepis’ efforts across the three pillars of sustainability and commitment (supply chain and environmental management, healthy and safe workplace culture, and corporate governance) to developing long-term ESG initiatives which will be navigated by a dedicated ESG team.

The decade of commitment and dedication of Samsung Bioepis to becoming the world’s leading biopharmaceuticals can be found at www.samsungbioepis.com and the company’s full ESG report can be viewed at https://bit.ly/33AybZx.

About Samsung Bioepis Co., Ltd.

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world’s leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology, hematology, endocrinology and gastroenterology. For more information, please visit: www.samsungbioepis.com and follow us on social media – Twitter, LinkedIn.

MEDIA CONTACT

[EU news release] Yoon Kim, yoon1.kim@samsung.com

[US news release] Anna Nayun Kim, nayun86.kim@samsung.com

[ROW news release] Jane Chung, ejane.chung@samsung.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/909b0207-cba0-4024-b865-46fb68afd694